Semler Scientific, Inc.

Semler Scientific, Inc.

Semler Scientific, Inc.

Overview
Date Founded

2013

Headquarters

2340-2348 Walsh Avenue,Suite 2344,Santa Clara, CA 95051

Type of Company

Public

Employees (Worldwide)

86

Industries

Printing
Biotechnology
Medical Products & Equipment
Hospitals & Patient Services

Company Description

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.

Contact Data
Trying to get in touch with decision makers at Semler Scientific, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer, Secretary & Director

Chief Marketing Officer

Chief Technical Officer

Senior Vice President-Finance & Accounting

Vice President of Finance & Principal Accounting Officer

Co-Founder

Co-Founder

Board of Directors

Chief Executive Officer, Secretary & Director at Semler Scientific, Inc.

Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.

Co-Founder at Health Advocate, Inc.

Vice President, Health Care Payment & Delivery Reform at Hart Health Strategies

Former President, Chief Executive Officer & Director at Magellan Health, Inc.

Co-Founder at Semler Scientific, Inc.

Paths to Semler Scientific, Inc.
Potential Connections via
Relationship Science
You
Semler Scientific, Inc.
Owners & Shareholders
Details Hidden

PWAM employs an opportunistic investment strategy. The firm generally pursues three main hedge fund strategies: long/short (hedged equity) investing, event-driven investing and credit/high yield investing. While the firm focuses on these strategies, they may engage in other strategies from time-to-time to take advantage of changing market conditions and other investment opportunities.

Details Hidden

NCM utilizes a long-term fundamental value investing methodology with a primary focus on small to mid-sized US companies. They practice research intensive, fundamental security selection and base their investment decisions on internally generated research and research obtained from outside sources. The firm focuses on intrinsic value by identifying securities which are mispriced relative to the real economic value they represent and on the expected timing for the mispricing to be corrected by market forces.

Details Hidden

Opaleye Management's strategy for managing their fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology and specialty pharmaceutical and device companies, which may include private companies. Typically, these are companies that are developing therapies and treatments intended for humans. The fund focuses its long investments in equity securities of companies that may not be profitable yet but whose share price may grow significantly in the near term or over a 1-2 year or longer period based on their therapeutic development and financial objectives. The fund also aims to actively invest in stock and derivative transactions to profit from binary events, such as clinical data milestones or a US Food and Drug Administration (FDA) regulatory decision. Conversely, the fund seeks opportunities to short securities that have extended valuations relative to the marketplace. Opaleye Management employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition.

Recent Transactions
Details Hidden

Semler Scientific, Inc. issued USD Common Stock

Insider Transactions
Transaction Advisors
Underwriter

Advised onSemler Scientific, Inc. issued USD Common Stock

Auditor

Advised onSemler Scientific, Inc. issued USD Common Stock

Advisors & Consultants
Consultant

Former Chief Financial & Accounting Officer at Sonim Technologies, Inc.

Publicist

Investor Relations Contact at S.A. Noonan Communications

Clients

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

Key Stats and Financials As of 2020
Market Capitalization
$731M
Total Enterprise Value
$736M
Earnings Per Share
$1.74
Net Profit
$14M
EBITDAMargin
42.84%
Total Debt
$0
Total Equity
$29.8M
Enterprise Value / Sales
19.07x
Enterprise Value EBITDAOperating
44.51x
TEVNet Income
52.56x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
45.81%
EBITDA
$16.5M
Revenue
$38.6M
Non-Profit Donations & Grants
Investors
Details Hidden

PWAM employs an opportunistic investment strategy. The firm generally pursues three main hedge fund strategies: long/short (hedged equity) investing, event-driven investing and credit/high yield investing. While the firm focuses on these strategies, they may engage in other strategies from time-to-time to take advantage of changing market conditions and other investment opportunities.

Details Hidden

Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm is currently looking for investment opportunities in medical-related start-ups.

Details Hidden

.Satwik Ventures LLC invests in companies located in the US. The firm provides financing for early stage capital requirements.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Semler Scientific, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Semler Scientific, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Semler Scientific, Inc..